Skip to content

Author

Emtenan M. Alharbi

We have 3 of 7 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Progress in Anti-Obesity Drug Development: A Pharmacodynamics Perspective

A pharmacodynamics-focused synthesis of current and emerging anti-obesity medications, emphasizing mechanistic targets, receptor interactions, and translational implications is provided, highlighting the need for individualized dosing strategies.

Ishtiaque Ahmad, Sarfuddin Azmi, Monirah A. Albabtain et al. · 0 citations
Review Open access Oct 2026

Self-Reported Provision of Community Pharmacy Services and Perceived Barriers in Saudi Arabia: A Cross-Sectional Survey

Routine counselling was commonly reported, whereas most extended services were infrequent, and exploratory analyses identified an inverse statistical relationship between perceived barriers and extended-service provision.

Emtenan M. Alharbi, Manal M. Alharbi, Amal Aldarwesh et al. · 0 citations
#explainable ai Review Open access Oct 2026

Artificial Intelligence in Eye Disease: A Systematic Review of Screening, Diagnosis, Prognosis, Treatment-Response Prediction, and Clinical Decision Support

Background/Objectives: Artificial intelligence (AI) is expanding eye care beyond image-based detection toward prognosis, treatment-response prediction, monitoring, triage, and clinician-facing decision support. We evaluated AI across eye-disease screening, diagnosis, prognosis, treatment response, and decision support,...

Manal M. Alharbi, Emtenan M. Alharbi, Alanoud Suliman Alsalamah et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.